Effects of exercise and airway clearance (PEP) on mucus clearance in cystic fibrosis: a randomised cross-over trial

CoughPulmonary Fibrosis

The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial

Ronchetti K, Tame JD, Paisey C, Thia LP, Doull I, Howe R, Mahenthiralingam E, Forton JT

doi: 10.1016/

Pulmonary Fibrosis

Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis

Radiology.

Dournes G, Berger P, Refait J, Macey J, Bui S, Delhaes L, Montaudon M, Corneloup O, Chateil JF, Marthan R, Fayon M, Laurent F

doi: 10.1148/radiol.2017162350.

RECOMMENDED

Pulmonary Fibrosis

Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial

Lancet Respir Med.

Ratjen F, Davis SD, Stanojevic S, Kronmal RA, Hinckley Stukovsky KD, Jorgensen N, Rosenfeld M, SHIP Study Group.

doi: 10.1016/S2213-

COMMENTED

Inhaled mannitol for cystic fibrosis

Cochrane Database Syst Rev.

Nevitt SJ, Thornton J, Murray CS, Dwyer T

doi: 10.1002/14651858.

The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial

BMC Pulm Med.

Dentice RL, Elkins MR, Dwyer GM, Bye PTP

doi: 10.1186/s12890-017-0568-2.

Clinical Model of Exercise-Related Dyspnea in Adult Patients With Cystic Fibrosis

J Cardiopulm Rehabil Prev.

Stevens D, Neyedli HF

doi: 10.1097/

RECOMMENDED

Bronchi

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials

Lancet Respir Med.

Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE

doi: 10.1016/S2213-2600(18)30427-2.

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial

Lancet Respir Med.

Ratjen F, Hug C, Marigowda G, Tian S, Huang X, Stanojevic S, Milla CE, Robinson PD, Waltz D, Davies JC; VX14-809-109 investigator group

doi: 10.1016/

Pulmonary FibrosisBronchi

Quantitative assessment of airway dimensions in young children with cystic fibrosis lung disease using chest computed tomography

Pediatr Pulmonol.

Kuo W, Soffers T, Andrinopoulou ER, Rosenow T, Ranganathan S, Turkovic L, Stick SM, Tiddens HAWM; AREST CF

doi: 10.1002/ppul.23787.

Related content

The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial

Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis

Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial

Inhaled mannitol for cystic fibrosis

The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial

Clinical Model of Exercise-Related Dyspnea in Adult Patients With Cystic Fibrosis

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial

Quantitative assessment of airway dimensions in young children with cystic fibrosis lung disease using chest computed tomography